SCHEMBL6031429

SCHEMBL6031429

CN(C)CCn1c2c(c3ccccc31)CCCC2NC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 4/20 0.48
▸ HRH2 P25021 2/20 0.48
▸ HRH1 P35367 2/20 0.48
▸ HRH3 Q9Y5N1 2/20 0.48
▸ CHRM2 P08172 1/20 0.48
▸ HTR1A P08908 1/20 0.48
▸ CHRM5 P08912 1/20 0.48
▸ ADRA2A P08913 1/20 0.48
▸ DRD2 P14416 1/20 0.48
▸ ADRA2B P18089 1/20 0.48
▸ ADRA2C P18825 1/20 0.48
▸ CHRM3 P20309 1/20 0.48
▸ DRD4 P21917 1/20 0.48
▸ SLC6A2 P23975 1/20 0.48
▸ HTR2A P28223 1/20 0.48
▸ HTR2C P28335 1/20 0.48
▸ AVPR2 P30518 1/20 0.48
▸ ADRA1A P35348 1/20 0.48
▸ DRD3 P35462 1/20 0.48
▸ OPRK1 P41145 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6031575 0.83 RB1 (0.45) RB1SLC2A1CYP3A4HPGDTBXA2R
SCHEMBL6029922 0.76 RB1 (0.48) RB1SLC2A1ALDH1A1HPGDHSD17B10
SCHEMBL6033064 0.76 RB1 (0.50) RB1SLC2A1ALDH1A1HPGDMAPK1
SCHEMBL25818911 0.72 HTR6 (0.85) HTR6HRH2HRH1HRH3CHRM2
SCHEMBL11632574 0.69 HTR6 (0.44) HTR6HRH2HRH1HRH3CHRM2
SCHEMBL24110035 0.67 HTR6 (0.53) HTR6HRH2HRH1HRH3CHRM2
SCHEMBL11826363 0.66 CYP2D6 (0.59) HTR6HRH2HRH1HRH3CHRM2
SCHEMBL7412035 0.66 HTR6 (0.55) HTR6HRH2HRH1HRH3CHRM2
SCHEMBL24110458 0.66 HTR6 (0.55) HTR6HRH2HRH1HRH3CHRM2
SCHEMBL4041356 0.66 HSD17B10 (0.43) HTR2AHTR2CKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678137-A1 COMPOSITIONS AND METHODS FOR VIRAL INHIBITION CHIRON CORPORATION (US) 2006-07-12 — — EP disclosed
WO-2005037791-A1 COMPOSITIONS AND METHODS FOR VIRAL INHIBITION CHIRON CORPORATION (US) 2005-04-28 — — WO disclosed
Send feedback